Rapid sodium periodate cleavage of an unnatural amino acid enables unmasking of a highly reactive α-oxo aldehyde for protein bioconjugation by Brabham, Robin et al.
This is a repository copy of Rapid sodium periodate cleavage of an unnatural amino acid 
enables unmasking of a highly reactive α-oxo aldehyde for protein bioconjugation.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/161006/
Version: Published Version
Article:
Brabham, Robin, Keenan, Tessa, Husken, Annika et al. (5 more authors) (2020) Rapid 
sodium periodate cleavage of an unnatural amino acid enables unmasking of a highly 
reactive α-oxo aldehyde for protein bioconjugation. Organic and Biomolecular Chemistry. 
ISSN 1477-0520 
https://doi.org/10.1039/d0ob00972e
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
This article is distributed under the terms of the Creative Commons Attribution (CC BY) licence. This licence 
allows you to distribute, remix, tweak, and build upon the work, even commercially, as long as you credit the 
authors for the original work. More information and the full terms of the licence here: 
https://creativecommons.org/licenses/ 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
Organic &
Biomolecular Chemistry
COMMUNICATION
Cite this: DOI: 10.1039/d0ob00972e
Received 11th May 2020,
Accepted 14th May 2020
DOI: 10.1039/d0ob00972e
rsc.li/obc
Rapid sodium periodate cleavage of an unnatural
amino acid enables unmasking of a highly reactive
α-oxo aldehyde for protein bioconjugation†
Robin L. Brabham, ‡a Tessa Keenan, ‡a Annika Husken,a Jacob Bilsborrow, a
Ryan McBerney,b Vajinder Kumar,b,c W. Bruce Turnbull b and
Martin A. Fascione *a
The α-oxo aldehyde is a highly reactive aldehyde for which many
protein bioconjugation strategies exist. Here, we explore the
genetic incorporation of a threonine-lysine dipeptide into proteins,
harbouring a “masked” α-oxo aldehyde that is rapidly unveiled in
four minutes. The reactive aldehyde could undergo site-specific
protein modification by SPANC ligation.
Genetic code expansion has revolutionised our ability to site-
selectively install unnatural functionality into proteins.1 The
use of the pyrrolysine (Pyl) tRNACUA/pyrrolysyl-tRNA synthetase
(RS) pair has proven to be a highly successful platform for this
purpose, with the introduction of reactive handles such as
azides,2 alkenes3–5 and alkynes6–8 into proteins, opening up a
wide range of site-specific chemical bioconjugation strategies.
The aldehyde is a particularly versatile functional group owing
to its unique reactivity, stability and relatively low abundance
in nature, however few examples of the site-specific installation
of aldehydes into proteins by amber stop codon suppression
have been reported, despite the many bioorthogonal method-
ologies available that utilise these functional handles.9
Notably, through the use of a mutant Pyl tRNA-RS pair from
Methanocaldococcus janaschii, an aldehyde-containing phenyl-
alanine analogue was previously shown to be incorporated into
a protein, facilitating modification by oxime ligation.10 This
finding breathed fresh life into well-established protein carbo-
nyl chemical modification, which had been hampered by the
limitations on the positioning of the required reactive alde-
hydes. Previous methods to install protein aldehydes required
an enzymatic tag, such as the use of FGE11 or an exposed
N-terminal serine, threonine or glycine residue;9 through the
use of amber stop codon suppression, site-specific protein
aldehyde modification could now move beyond such sequence
limitations.
Aldehydes can differ vastly in their electronic properties,
dictated by the method used for their installation.9 The α-oxo
aldehyde is a highly reactive aldehyde for which many reliable
protein bioconjugation methodologies have been
established.9,12 Previously restricted to the N-terminus of a
protein and requiring an exposed seryl, threonyl or glycyl
residue for its formation, the site-specific incorporation of a
thiazolidine-protected α-oxo aldehyde into a protein was
recently demonstrated.13 We recently reported a biocompatible
method of unmasking a genetically encoded thiazolidine-pro-
tected α-oxo aldehyde in a protein, using stoichiometric allyl-
palladium(II) chloride.14 However, this procedure requires
some optimisation for individual proteins, in order to balance
the reactivity of the palladium complex to open the thiazoli-
dine with potential side-reactions including protein precipi-
tation. In this work, we explore an alternative route to the site-
specific installation of a α-oxo aldehyde, through the genetic
incorporation of a threonine-lysine derivative, and its rapid
unmasking within four minutes (Fig. 1). The reactivity of the
α-oxo aldehyde in site-selective protein modification was sub-
sequently demonstrated by Strain-Promoted Alkyne-Nitrone
Cycloaddition (SPANC) ligation.
To generate a protein α-oxo aldehyde, we explored the peri-
odate-mediated cleavage of a genetically encoded ε-lysine
dipeptide harbouring a 1,2-amino alcohol motif, arising from
a serine or threonine residue. In order to maximise the
chances of discovering a suitable substrate for amber stop
codon suppression, four dipeptides (1–4) were synthesised,
differing in the absence/presence of a β-methyl group (serine/
threonine respectively) and the α-configuration (S/R, “natural”
vs. “unnatural” respectively) (Fig. 2). The modulation of
α-configuration and β-methyl groups was considered to offer
insight into the amber stop codon suppression process, with
these changes subtly altering amino acid polarity, steric bulk,
and positioning within the pylS active site. An activation-coup-
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ling-deprotection strategy was used to synthesise all four
dipeptides in three steps with cumulative yields of 39% (1),
50% (2), 32% (3) and 56% (4) respectively (Schemes S1 and S2,
ESI†). Considering that the promiscuity of the wild type
M. mazei Pyl tRNA-RS pair had been shown to extend to several
lysine dipeptides,14–16 we chose to investigate this pair for the
genetic incorporation of our dipeptides 1–4. To screen the suit-
ability of the dipeptides 1–4 as substrates for the M. mazei Pyl
tRNA-RS pair, an expression trial using EGFP(Y39TAG)-His6 as
a reporter protein was carried out and the samples were ana-
lysed by SDS-PAGE (Fig. 2). EGFP(Y39TAG), containing an
amber mutation at surface-exposed position Y39,17 was
selected due to its ease of visualisation and highly optimised
expression system for use with unnatural amino acid (UAA)
mutagenesis. The known Pyl tRNA-RS pair substrate Nε-pro-
pargyloxycarbonyl-L-lysine 5 served as a positive control for the
expression trial.18 As expected, a thick band corresponding to
the overexpression of EGFP was observed in the positive
control lane 5, at the expected molecular mass of ∼28 kDa.
Interestingly, only the Thr-Lys dipeptide 3 appeared to be
genetically incorporated into EGFP as demonstrated by a band
of overexpression observed at ∼28 kDa, albeit far less intense
than the corresponding band in the positive control 5. To
further validate these observations, the cell lysates were
observed under fluorescent light (Fig. S1, ESI†). As expected,
strong fluorescence was observed in the positive control 5 and
mild fluorescence in Thr-Lys dipeptide 3 cell lysates respect-
ively, while no fluorescence was observed in all other cell
lysates. Genetic incorporation of dipeptides 1–4 into EGFP was
also attempted with the Pyl tRNA-RS pair Y306A Y384F
mutant,19 however none of the dipeptides were successfully
incorporated (data not shown). A possible explanation for a
threonine derivative being a superior PylRS substrate to a
serine derivative, is that the extra methyl group can better
occupy the hydrophobic space within the substrate binding
pocket.20
Following the identification of a suitable dipeptide sub-
strate for the M. mazei Pyl tRNA-RS pair to facilitate the site-
specific installation of a α-oxo aldehyde into a protein, the
Thr-Lys dipeptide 3 was also introduced into sfGFP at the
surface exposed position N150,21 using a method of amber
stop codon suppression adapted for GFP expression.14 The
cells were cultivated in Terrific Broth medium supplemented
with 0.02% arabinose and 1.5 mM of Thr-Lys dipeptide 3, pro-
moting the expression of the full-length sfGFP(N150ThrK)-His6
protein 6. Following purification by Ni2+ affinity chromato-
graphy, the purity and molecular mass of 6 was validated by
SDS-PAGE and ESI-FTICR-MS (Fig. S2 and S3, ESI†). Following
the successful incorporation of the Thr-Lys dipeptide 3, peri-
odate-mediated oxidation of the 1,2-aminoalcohol motif in the
threonine residue was explored (Fig. 3). Whilst periodate-
mediated oxidation of 1,2-aminoalcohols is generally fast, peri-
odate will also oxidise other amino acid residues in proteins,
including cysteine, methionine, tryptophan, tyrosine, and his-
tidine, albeit more slowly and dependent on the experimental
conditions.12,22 However, protein over-oxidation can be
avoided by performing the reaction at neutral pH, controlling
the reaction stoichiometry and minimising the reaction time.
Additionally, excess methionine or ethylene glycol should be
added either during or after the reaction, to quench the
unreacted periodate.12 Based on conditions previously opti-
mised for oxidising an N-terminal serine residue in an EGFP
mutant,23 oxidation was first attempted in phosphate buffered
saline (PBS) using 3, 5 and 10 eq. of NaIO4, and 6, 10 and 20
eq. of L-methionine, respectively (Fig. 3a). Oxidation reactions
were allowed to proceed for 4–10 min, after which samples
were desalted and the amount of oxidised protein determined
after analysis by ESI-FTICR-MS. The addition of 3 eq. of NaIO4
and 6 eq. of L-methionine led to ∼59% conversion in 4 min.
Attempts to increase this conversion were largely unsuccessful.
Longer reaction times and greater eq. of NaIO4 and
L-methionine led to no improvement in conversion, and in
some cases undesired off-target oxidation of the protein was
observed. Reviewing literature protocols led to closer inspec-
tion of the buffer composition used. Sodium phosphate
buffers are commonplace, as is the use of NaCl, but potassium
ions are seldom encountered. One hypothesis is that potass-
Fig. 1 New route for the site-selective installation of a α-oxo aldehyde into proteins.
Fig. 2 Screening of lysine dipeptides 1–4 for their incorporation into
EGFP at position Y39 by the M. mazei Pyl tRNA-RS pair and analysis by
SDS-PAGE. The full uncropped SDS-PAGE gel is included in the ESI
(Fig. S7†).
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ium cations may interact with the periodate anion and precipi-
tate as potassium periodate, poorly soluble in water (ca. 8 mM)
at the typical 0 °C of periodate oxidation, as was observed in
early applications of periodate oxidation.24 Given that period-
ate was only used in 5 eq., even minor precipitation of period-
ate could noticeably affect the extent and rate of oxidation.
With this consideration in mind, the oxidation was repeated in
a potassium-free system using 20 mM sodium phosphate (PB),
150 mM NaCl buffer pH 7.4 with 5 eq. of NaIO4 and 10 eq. of
L-methionine, for 4 min. These conditions resulted in com-
Fig. 3 (a) Optimisation of oxidation conditions to unmask the α-oxo aldehyde in sfGFP(N150ThrK)-His6 6. % oxidised product was determined by
ESI-FTICR-MS analysis (b) deconvoluted ESI-FTICR mass spectrum showing the complete oxidation of 6 (left) to form 7 (right) (experimental masses
shown).
Fig. 4 SPANC ligation of protein aldehyde 7 with BCN biotin probe 8 or BCN dansyl probe 10 (top). In both cases, ESI-FTICR-MS data show the
complete consumption of 7-ald to afford biotinylated protein 9 (a) (calc. 28822 Da, found 28824 Da) and dansylated protein 11 (b) (calc. 28829 Da,
found 28831 Da). (c) Protein modification validated by Coomassie-stained SDS-PAGE (upper) and protein in-gel fluorescence (middle, 11) or western
blotting with an anti-biotin probe (lower, 9). The uncropped SDS-PAGE gels and western blot are shown in the ESI (Fig. S9†).
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plete oxidation of 6 to 7 (Fig. 3b). In this example 7 exists
almost completely as the hydrate. The effect of removing pot-
assium, a seemingly innocuous buffer component, is easily
overlooked yet remarkably profound here.
To demonstrate the reactivity of the newly exposed α-oxo
aldehyde, SPANC ligation was explored. SPANC ligation is a
one-pot modification strategy in which a nitrone, formed
in situ from a protein glyoxyl aldehyde and an N-substituted
hydroxylamine, undergoes a [3 + 2] cycloaddition with a
strained alkyne, typically a cyclooctyne or a BCN.25,26 SPANC
ligations are generally performed at pH 6.8 in NH4OAc buffer,
with the addition of p-anisidine which has been shown to
enhance the rate of the SPANC ligation.26 SPANC ligation was
used to modify 7 with a biotin bicyclononyne (BCN) probe 8,
to afford biotinylated protein 9. Complete conversion was
observed within 18 h, as determined by ESI-FTICR-MS
(Fig. 4a). The successful incorporation of the biotin in probe 9
was further validated by western blotting (Fig. 4c). To further
showcase the utility of the unmasked α-oxo aldehyde in 7, the
protein was also fluorescently labelled by SPANC ligation using
dansyl BCN probe 10, to afford dansylated protein 11. Again,
complete conversion was validated by ESI-FTICR-MS (Fig. 4b)
and the successful incorporation of the dansyl group into 11
was visualised through denatured protein in-gel fluorescence
(Fig. 4c). The unmasked protein α-oxo aldehyde has been suc-
cessfully shown to undergo bioconjugation by SPANC, which
was previously only accessible on N-terminal α-oxo aldehydes.
In summary, we have shown the genetic incorporation of a
new NCAA 3 into proteins, harbouring a “masked” α-oxo alde-
hyde, by using the highly promiscuous M. mazei Pyl tRNA-RS
pair. The NCAA 3 was produced by using a straightforward three-
step synthesis. We have demonstrated the rapid unmasking of
the highly reactive α-oxo aldehyde by using NaIO4 oxidation
within 4 min and demonstrated its utility in protein bioconjuga-
tion by using SPANC ligation to confer avidin affinity or fluo-
rescent functionality, through the use of reactive probes bearing
biotin or dansyl groups. This work has shown that SPANC bio-
conjugations are not limited in scope to the N-terminus, remov-
ing a heavy restriction on the use of this chemistry. The “internal
α-oxo aldehyde” exhibits comparable reactivity to an N-terminal
α-oxo aldehyde and presents new opportunities for site-selective
protein modification beyond the protein N-terminus by a range
of bioconjugation strategies including hydrazone ligation, thia-
zolidine ligation, oxime ligation and organocatalyst-mediated
protein aldol ligation (OPAL) chemistry.12,23
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